Meet
Emily Sobel

Emily Sobel provides research and strategic support to health plans and pharmaceutical clients on federal and state health policy activities.

With experience spanning the pharmaceutical industry, provider associations, and advocacy groups, she assists clients in analyzing and reacting to diverse health policy issues.

Prior to joining Avalere, Emily was an associate consultant on the healthcare team at APCO Worldwide, providing strategic policy and issues management counsel to private sector clients across the healthcare industry, including policy and regulatory landscape analysis to inform advocacy and product decisions. Prior to that, as a federal government affairs analyst at Sanofi US, she conducted research on national and global healthcare policy issues with a focus on the Affordable Care Act and vaccines.

Emily has a BA from Duke University in public policy studies.

Authored Content


On June 14, Avalere experts came together with Cynthia Tudor, former Deputy Center Director of the Center for Medicare and Senior Advisor to Avalere, to discuss vaccine coverage and access challenges under Medicare.

A proposed shift of Part B drugs into Part D could affect patient access and increase the burden on providers.

Avalere experts discuss adult immunization rates in the United States and how the disparate coverage of vaccines under Medicare creates significant barriers to increasing adult immunization uptake.

States can pursue various policy opportunities to encourage vaccination and increase access to vaccines.

Avalere has released a new white paper explaining the current insurance coverage requirements for vaccines and the laws that govern those requirements for the Medicare (Parts B and D), Medicaid, and commercial (group and individual) markets.